Bayesian Capital Management’s Omnicell OMCL Stock Holding History

Bayesian Capital Management’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8,401	Closed	-$294K	–	780
2025 Q1	$294K	Buy	+8,401	New	+$333K	0.05%	395
2024 Q2	–	Sell	-13,600	Closed	-$398K	–	995
2024 Q1	$398K	Buy	+13,600	New	+$412K	0.04%	487
2023 Q2	–	Sell	-23,544	Closed	-$1.38M	–	990
2023 Q1	$1.38M	Buy	+23,544	New	+$1.3M	0.17%	182
2020 Q1	–	Sell	-3,411	Closed	-$279K	–	923
2019 Q4	$279K	Sell	3,411 -770	-18%	-$59.1K	0.05%	447
2019 Q3	$302K	Buy	4,181 +1,400	+50%	+$103K	0.06%	363
2019 Q2	$239K	Sell	2,781 -2,300	-45%	-$187K	0.05%	410
2019 Q1	$411K	Buy	5,081 +800	+19%	+$59.9K	0.08%	330
2018 Q4	$262K	Sell	4,281 -984	-19%	-$66.6K	0.05%	446
2018 Q3	$379K	Buy	+5,265	New	+$332K	0.06%	390
2017 Q4	–	Sell	-7,182	Closed	-$367K	–	673
2017 Q3	$367K	Buy	+7,182	New	+$344K	0.09%	325

Other funds holding OMCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Bayesian Capital Management's OMCL Position: Q2 2025 in Review

Bayesian Capital Management sold out of Omnicell (OMCL) in Q2 2025, closing a stake of 8,401 shares — an estimated $294K sold.

Bayesian Capital Management first reported a position in OMCL in Q3 2017 and held it in 10 quarters. The position peaked at $1.38M in Q1 2023. 247 funds tracked by Wall St. Rank hold OMCL as of Q2 2025.

Bayesian Capital Management reported no remaining Omnicell position as of Q2 2025 after selling out during the quarter.
Bayesian Capital Management sold 8,401 Omnicell shares in Q2 2025, an estimated $294K.
Bayesian Capital Management first reported a position in Omnicell in Q3 2017 and held it in 10 quarters.
Bayesian Capital Management's Omnicell position peaked at $1.38M in Q1 2023.
247 funds tracked by Wall St. Rank held Omnicell as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.